Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Specialized Health Products International (SHPI) was a medical device company specializing in the development and manufacture of safety-engineered needles and syringes. The company's primary focus was on reducing the incidence of accidental needlestick injuries among healthcare workers through proprietary safety mechanisms. Their flagship products included safety Huber needles, such as the Lift-Loc and SafeStep brands, which are used for accessing implanted ports. SHPI's business model included both direct sales and licensing its safety technologies to major medical supply companies. In 2008, the company was acquired by C. R. Bard for approximately $113 million, becoming part of Bard's Access Systems division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Specialized Health Products International.